Clinical Trials Logo

Clinical Trial Summary

The understanding, utilization and uptake of Family Health History is essential to the prevention of health disparities in the African American community. Creating a culturally tailored Family Health History tool, co-developed by members of the African American community will inform, educate and empower African Americans about health issues related to their family genealogy. Applying the knowledge gained via Family Health Histories to increase preventative behaviors including screenings thus linking people to needed health services to prevent the onset of disease and illness.


Clinical Trial Description

African Americans (AA) suffer disproportionately across most health disparities (HD). Preventative behaviors including screenings can inform proactive measures to address many HD which include: diabetes, heart disease, high blood pressure, stroke, HIV, STDs/STIs, cancer, and cardiovascular disease, most of which can be prevented.1-3 Evidence suggests that a lack of general health literacy (HL) and racially appropriate health communication strategies may contribute to the consistent high rates of health disparities in the AA community. Family Health Histories (FHH), which describe genetic and other familial contributions to health, have been identified as an effective tool for prevention and early detection and screenings. The underutilization of FHHs in AA communities negatively impacts screening and preventative measures that could prevent the onset of disease, illness and ultimately death.4 Although many FHH toolkits have been created to assist families in gathering FHH information, these tools typically are mostly focused for the general population and do not account for the cultural and ethnic nuances, communication preference and health literacy levels of the African American community.4 The failure to effectively engage AA in the creation and conception of culturally relevant FHH tools and activities to date likely contributes to their underutilization in this population. The objective of this K01 is to develop culturally appropriate FHH tools designed for broad understanding and uptake in AA communities. The central hypothesis of this proposal is that, using a community based participatory research (CBPR) approach, co-development of a culturally appropriate FHH toolkit will increase the utility and engagement of AA families in FHH activities; increase effective health communication within the family structure; and increase the health literacy of participants in a multifaceted effort to reduce and ultimately eliminate racial and ethnic health disparities. Flint is an ideal community in which to conduct this participatory research because the recent events of the Flint Water Crisis have created interest in genetics and FHH in the AA community as a result of community concern around the generational impacts of bacteria and lead exposure on health. Therefore, we will have partners within AA communities in Flint who will be motivated to partner with us to develop these tools for Flint and for other minority communities. This career development award is being submitted by Dr. Kent Key, a candidate with extensive experience in CBPR and a solid foundation in qualitative and health disparities research. To reach his long term goal of becoming an R01-funded researcher in CBPR to reduce health disparities by increasing health literacy and using effective health communication strategies to reduce and ultimately eliminate racial health disparities for African-American populations, this K01 will provide additional training in the following areas: (1) intervention development and design and conduct of randomized trials, (2) health communication models, (3) health literacy promotion, (4) CBPR approaches to Genomics and Genetics, (5) biostatistics, (6) grant-writing. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05358964
Study type Interventional
Source Michigan State University
Contact Kent D Key, PhD
Phone 810-600-5663
Email keykent@msu.edu
Status Recruiting
Phase N/A
Start date September 1, 2024
Completion date January 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06183138 - Multicenter Analysis of Genomic and Metabolic Data of Neonatal Genetic Diseases
Recruiting NCT06107400 - Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease Early Phase 1
Completed NCT00001466 - Study of Clinical and Molecular Manifestations of Genetic Disorders N/A
Active, not recruiting NCT04428710 - Assessment Psychological Distress for Cancer Heredity Test
Recruiting NCT04531696 - UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research N/A
Completed NCT01343953 - Cord Blood Transplantation in Severe Aplastic Anemia Phase 2
Enrolling by invitation NCT05721326 - Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition N/A
Enrolling by invitation NCT04548921 - Biomarker for Friedreich's Ataxia (BioFridA)
Recruiting NCT06330441 - Pancreatic Cancer Screening in a Population at High Risk N/A
Completed NCT02416440 - Durban Diabetes Study:A Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent (DDS) Phase 0
Recruiting NCT05587439 - Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Withdrawn NCT04531878 - BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases Phase 2/Phase 3
Completed NCT02917070 - Parental Consanguinity and Family History of Kidney Disease in Turkish Kidney Disease Population N/A
Active, not recruiting NCT01645904 - A Social Media Approach to Improve Genetic Risk Communication Phase I
Recruiting NCT05161169 - Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants N/A
Recruiting NCT06157983 - Evaluation of Cascade Screening for Elevated Lipoprotein(a)
Active, not recruiting NCT04528498 - Embryo Health Study
Completed NCT05453474 - Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling N/A
Terminated NCT00314691 - Development of New Prenatal Diagnostic Tests From Maternal Blood N/A